Studies on the characteristics of the control system governing sodium excretion in uremic man.
Sodium excretion was studied in a group of patients with chronic renal disease, (a) on constant salt intakes of varying amounts with and without mineralocorticoid hormone administration and, (b) after acute extracellular fluid volume expansion. The lower the steady-state glomerular filtration rate (GFR), the greater was the fraction of filtered sodium excreted on both a 3.5 and 7.0 g salt diet; and the lower the GFR, the greater was the change in fractional excretion in the transition from the 3.5 to the 7.0 g salt diet. This regulatory capacity did not appear to be influenced by mineralocorticoid hormone administration. After acute expansion of extracellular fluid (ECF) volume, the increment in sodium excretion exceeded the concomitant increment in filtered sodium in six of nine studies and in the remaining three studies, the increment in excretion averaged 59% of the Delta filtered load (i.e., only 41% of the increase in filtered sodium was reabsorbed). During saline loading, the decrease in fractional reabsorption of sodium tended to vary inversely with the steady-state GFR, although all patients received approximately the same loading volume. When an edema-forming stimulus was applied during saline infusion, the natriuretic response was aborted and the lag time was relatively short. When GFR and the filtered load of sodium were increased without volume expansion, the Delta sodium excretion averaged only 19% of the Delta filtered load; moreover, changes in fractional sodium reabsorption were considerably smaller than those observed during saline loading. The data implicate the presence of a factor other than GFR and mineralocorticoid changes in the modulation of sodium excretion in uremic man.
D000042:Absorption; D001794:Blood Pressure; D004035:Diet Therapy; D004487:Edema; D005110:Extracellular Space / Q000187:drug effects; D005919:Glomerular Filtration Rate; D005921:Glomerulonephritis / Q000652:urine*; D006801:Humans; D008901:Mineralocorticoids / Q000008:administration & dosage; D010281:Parathyroid Hormone / Q000494:pharmacology; D007690:Polycystic Kidney Diseases / Q000652:urine*; D011704:Pyelonephritis / Q000652:urine*; D012492:Salts; D012964:Sodium / Q000378:metabolism / Q000652:urine*
D008901:Mineralocorticoids; D010281:Parathyroid Hormone; D012492:Salts; D012964:Sodium